カテゴリー： Market Monitor Global, 世界, 医療/バイオ

抗糖尿病薬の世界市場見通し2023年-2029年

◆英語タイトル：Antidiabetics Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23JU5677）

◆商品コード：MMG23JU5677
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年6月
◆ページ数：73
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医薬品＆医療

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Antidiabetics Market 調査レポートは次の情報を含め、グローバルにおけるの抗糖尿病薬市場規模と予測を収録しています。・世界の抗糖尿病薬市場：売上、2018年-2023年、2024年-2029年
・世界の抗糖尿病薬市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の抗糖尿病薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「1型糖尿病」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

抗糖尿病薬のグローバル主要企業は、Sanofi-Aventis、 Takeda Pharmaceuticals、 Eli Lilly、 Oramed Pharmaceuticals、 Boehringer Ingelheim、 Merck & Co. Inc.、 Novo Nordisk、 Bristol-Myers Squibb、 Halozyme Therapeutics、 Pfizerなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、抗糖尿病薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の抗糖尿病薬市場：タイプ別、2018年-2023年、2024年-2029年
世界の抗糖尿病薬市場：タイプ別市場シェア、2022年
・1型糖尿病、2型糖尿病、その他

世界の抗糖尿病薬市場：用途別、2018年-2023年、2024年-2029年
世界の抗糖尿病薬市場：用途別市場シェア、2022年
・病院、診療所、家庭、その他

世界の抗糖尿病薬市場：地域・国別、2018年-2023年、2024年-2029年
世界の抗糖尿病薬市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における抗糖尿病薬のグローバル売上、2018年-2023年
・主要企業における抗糖尿病薬のグローバル売上シェア、2022年
・主要企業における抗糖尿病薬のグローバル販売量、2018年-2023年
・主要企業における抗糖尿病薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Sanofi-Aventis、 Takeda Pharmaceuticals、 Eli Lilly、 Oramed Pharmaceuticals、 Boehringer Ingelheim、 Merck & Co. Inc.、 Novo Nordisk、 Bristol-Myers Squibb、 Halozyme Therapeutics、 Pfizer

*************************************************************

・調査・分析レポートの概要
抗糖尿病薬市場の定義
市場セグメント
世界の抗糖尿病薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の抗糖尿病薬市場規模
世界の抗糖尿病薬市場規模：2022年 VS 2029年
世界の抗糖尿病薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの抗糖尿病薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の抗糖尿病薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：1型糖尿病、2型糖尿病、その他
抗糖尿病薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、診療所、家庭、その他
抗糖尿病薬の用途別グローバル売上・予測

・地域別市場分析
地域別抗糖尿病薬市場規模 2022年と2029年
地域別抗糖尿病薬売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Sanofi-Aventis、 Takeda Pharmaceuticals、 Eli Lilly、 Oramed Pharmaceuticals、 Boehringer Ingelheim、 Merck & Co. Inc.、 Novo Nordisk、 Bristol-Myers Squibb、 Halozyme Therapeutics、 Pfizer
...

Type 1 Diabetes and Type 2 Diabetes are common types of diabetes. Treatments include (1) agents that increase the amount of insulin secreted by the pancreas, (2) agents that increase the sensitivity of target organs to insulin, and (3) agents that decrease the rate at which glucose is absorbed from the gastrointestinal tract.
This report aims to provide a comprehensive presentation of the global market for Antidiabetics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antidiabetics. This report contains market size and forecasts of Antidiabetics in global, including the following market information:
Global Antidiabetics Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Antidiabetics Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Antidiabetics companies in 2022 (%)
The global Antidiabetics market was valued at US$ 59860 million in 2022 and is projected to reach US$ 86650 million by 2029, at a CAGR of 5.4% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The North American antidiabetics market held the largest market revenue share in 2013. High market penetration of modern insulin products such as long-acting, rapid acting insulin analogs and DPP-4 drugs such as Januvia, Onglyza and Nesina and the presence of high healthcare expenditures, patient awareness levels, sophisticated healthcare infrastructure and reimbursement framework are the major factors contributing to its large share.
Asia Pacific on account of the rapidly improving healthcare expenditure levels, growing prevalence of type I and type II diabetes and increasing patient disposable incomes is expected to grow at the fastest rate during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Antidiabetics manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Antidiabetics Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Antidiabetics Market Segment Percentages, by Type, 2022 (%)
Type 1 Diabetes
Type 2 Diabetes
Other
Global Antidiabetics Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Antidiabetics Market Segment Percentages, by Application, 2022 (%)
Hospital Use
Clinic Use
Household
Other
Global Antidiabetics Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Antidiabetics Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Antidiabetics revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Antidiabetics revenues share in global market, 2022 (%)
Key companies Antidiabetics sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Antidiabetics sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sanofi-Aventis
Takeda Pharmaceuticals
Eli Lilly
Oramed Pharmaceuticals
Boehringer Ingelheim
Merck & Co. Inc.
Novo Nordisk
Bristol-Myers Squibb
Halozyme Therapeutics
Pfizer
Outline of Major Chapters:
Chapter 1: Introduces the definition of Antidiabetics, market overview.
Chapter 2: Global Antidiabetics market size in revenue and volume.
Chapter 3: Detailed analysis of Antidiabetics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Antidiabetics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Antidiabetics capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Antidiabetics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Antidiabetics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Antidiabetics Overall Market Size
2.1 Global Antidiabetics Market Size: 2022 VS 2029
2.2 Global Antidiabetics Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Antidiabetics Sales: 2018-2029
3 Company Landscape
3.1 Top Antidiabetics Players in Global Market
3.2 Top Global Antidiabetics Companies Ranked by Revenue
3.3 Global Antidiabetics Revenue by Companies
3.4 Global Antidiabetics Sales by Companies
3.5 Global Antidiabetics Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Antidiabetics Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Antidiabetics Product Type
3.8 Tier 1, Tier 2 and Tier 3 Antidiabetics Players in Global Market
3.8.1 List of Global Tier 1 Antidiabetics Companies
3.8.2 List of Global Tier 2 and Tier 3 Antidiabetics Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Antidiabetics Market Size Markets, 2022 & 2029
4.1.2 Type 1 Diabetes
4.1.3 Type 2 Diabetes
4.1.4 Other
4.2 By Type – Global Antidiabetics Revenue & Forecasts
4.2.1 By Type – Global Antidiabetics Revenue, 2018-2023
4.2.2 By Type – Global Antidiabetics Revenue, 2024-2029
4.2.3 By Type – Global Antidiabetics Revenue Market Share, 2018-2029
4.3 By Type – Global Antidiabetics Sales & Forecasts
4.3.1 By Type – Global Antidiabetics Sales, 2018-2023
4.3.2 By Type – Global Antidiabetics Sales, 2024-2029
4.3.3 By Type – Global Antidiabetics Sales Market Share, 2018-2029
4.4 By Type – Global Antidiabetics Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Antidiabetics Market Size, 2022 & 2029
5.1.2 Hospital Use
5.1.3 Clinic Use
5.1.4 Household
5.1.5 Other
5.2 By Application – Global Antidiabetics Revenue & Forecasts
5.2.1 By Application – Global Antidiabetics Revenue, 2018-2023
5.2.2 By Application – Global Antidiabetics Revenue, 2024-2029
5.2.3 By Application – Global Antidiabetics Revenue Market Share, 2018-2029
5.3 By Application – Global Antidiabetics Sales & Forecasts
5.3.1 By Application – Global Antidiabetics Sales, 2018-2023
5.3.2 By Application – Global Antidiabetics Sales, 2024-2029
5.3.3 By Application – Global Antidiabetics Sales Market Share, 2018-2029
5.4 By Application – Global Antidiabetics Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Antidiabetics Market Size, 2022 & 2029
6.2 By Region – Global Antidiabetics Revenue & Forecasts
6.2.1 By Region – Global Antidiabetics Revenue, 2018-2023
6.2.2 By Region – Global Antidiabetics Revenue, 2024-2029
6.2.3 By Region – Global Antidiabetics Revenue Market Share, 2018-2029
6.3 By Region – Global Antidiabetics Sales & Forecasts
6.3.1 By Region – Global Antidiabetics Sales, 2018-2023
6.3.2 By Region – Global Antidiabetics Sales, 2024-2029
6.3.3 By Region – Global Antidiabetics Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Antidiabetics Revenue, 2018-2029
6.4.2 By Country – North America Antidiabetics Sales, 2018-2029
6.4.3 US Antidiabetics Market Size, 2018-2029
6.4.4 Canada Antidiabetics Market Size, 2018-2029
6.4.5 Mexico Antidiabetics Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Antidiabetics Revenue, 2018-2029
6.5.2 By Country – Europe Antidiabetics Sales, 2018-2029
6.5.3 Germany Antidiabetics Market Size, 2018-2029
6.5.4 France Antidiabetics Market Size, 2018-2029
6.5.5 U.K. Antidiabetics Market Size, 2018-2029
6.5.6 Italy Antidiabetics Market Size, 2018-2029
6.5.7 Russia Antidiabetics Market Size, 2018-2029
6.5.8 Nordic Countries Antidiabetics Market Size, 2018-2029
6.5.9 Benelux Antidiabetics Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Antidiabetics Revenue, 2018-2029
6.6.2 By Region – Asia Antidiabetics Sales, 2018-2029
6.6.3 China Antidiabetics Market Size, 2018-2029
6.6.4 Japan Antidiabetics Market Size, 2018-2029
6.6.5 South Korea Antidiabetics Market Size, 2018-2029
6.6.6 Southeast Asia Antidiabetics Market Size, 2018-2029
6.6.7 India Antidiabetics Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Antidiabetics Revenue, 2018-2029
6.7.2 By Country – South America Antidiabetics Sales, 2018-2029
6.7.3 Brazil Antidiabetics Market Size, 2018-2029
6.7.4 Argentina Antidiabetics Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Antidiabetics Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Antidiabetics Sales, 2018-2029
6.8.3 Turkey Antidiabetics Market Size, 2018-2029
6.8.4 Israel Antidiabetics Market Size, 2018-2029
6.8.5 Saudi Arabia Antidiabetics Market Size, 2018-2029
6.8.6 UAE Antidiabetics Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Sanofi-Aventis
7.1.1 Sanofi-Aventis Company Summary
7.1.2 Sanofi-Aventis Business Overview
7.1.3 Sanofi-Aventis Antidiabetics Major Product Offerings
7.1.4 Sanofi-Aventis Antidiabetics Sales and Revenue in Global (2018-2023)
7.1.5 Sanofi-Aventis Key News & Latest Developments
7.2 Takeda Pharmaceuticals
7.2.1 Takeda Pharmaceuticals Company Summary
7.2.2 Takeda Pharmaceuticals Business Overview
7.2.3 Takeda Pharmaceuticals Antidiabetics Major Product Offerings
7.2.4 Takeda Pharmaceuticals Antidiabetics Sales and Revenue in Global (2018-2023)
7.2.5 Takeda Pharmaceuticals Key News & Latest Developments
7.3 Eli Lilly
7.3.1 Eli Lilly Company Summary
7.3.2 Eli Lilly Business Overview
7.3.3 Eli Lilly Antidiabetics Major Product Offerings
7.3.4 Eli Lilly Antidiabetics Sales and Revenue in Global (2018-2023)
7.3.5 Eli Lilly Key News & Latest Developments
7.4 Oramed Pharmaceuticals
7.4.1 Oramed Pharmaceuticals Company Summary
7.4.2 Oramed Pharmaceuticals Business Overview
7.4.3 Oramed Pharmaceuticals Antidiabetics Major Product Offerings
7.4.4 Oramed Pharmaceuticals Antidiabetics Sales and Revenue in Global (2018-2023)
7.4.5 Oramed Pharmaceuticals Key News & Latest Developments
7.5 Boehringer Ingelheim
7.5.1 Boehringer Ingelheim Company Summary
7.5.2 Boehringer Ingelheim Business Overview
7.5.3 Boehringer Ingelheim Antidiabetics Major Product Offerings
7.5.4 Boehringer Ingelheim Antidiabetics Sales and Revenue in Global (2018-2023)
7.5.5 Boehringer Ingelheim Key News & Latest Developments
7.6 Merck & Co. Inc.
7.6.1 Merck & Co. Inc. Company Summary
7.6.2 Merck & Co. Inc. Business Overview
7.6.3 Merck & Co. Inc. Antidiabetics Major Product Offerings
7.6.4 Merck & Co. Inc. Antidiabetics Sales and Revenue in Global (2018-2023)
7.6.5 Merck & Co. Inc. Key News & Latest Developments
7.7 Novo Nordisk
7.7.1 Novo Nordisk Company Summary
7.7.2 Novo Nordisk Business Overview
7.7.3 Novo Nordisk Antidiabetics Major Product Offerings
7.7.4 Novo Nordisk Antidiabetics Sales and Revenue in Global (2018-2023)
7.7.5 Novo Nordisk Key News & Latest Developments
7.8 Bristol-Myers Squibb
7.8.1 Bristol-Myers Squibb Company Summary
7.8.2 Bristol-Myers Squibb Business Overview
7.8.3 Bristol-Myers Squibb Antidiabetics Major Product Offerings
7.8.4 Bristol-Myers Squibb Antidiabetics Sales and Revenue in Global (2018-2023)
7.8.5 Bristol-Myers Squibb Key News & Latest Developments
7.9 Halozyme Therapeutics
7.9.1 Halozyme Therapeutics Company Summary
7.9.2 Halozyme Therapeutics Business Overview
7.9.3 Halozyme Therapeutics Antidiabetics Major Product Offerings
7.9.4 Halozyme Therapeutics Antidiabetics Sales and Revenue in Global (2018-2023)
7.9.5 Halozyme Therapeutics Key News & Latest Developments
7.10 Pfizer
7.10.1 Pfizer Company Summary
7.10.2 Pfizer Business Overview
7.10.3 Pfizer Antidiabetics Major Product Offerings
7.10.4 Pfizer Antidiabetics Sales and Revenue in Global (2018-2023)
7.10.5 Pfizer Key News & Latest Developments
8 Global Antidiabetics Production Capacity, Analysis
8.1 Global Antidiabetics Production Capacity, 2018-2029
8.2 Antidiabetics Production Capacity of Key Manufacturers in Global Market
8.3 Global Antidiabetics Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Antidiabetics Supply Chain Analysis
10.1 Antidiabetics Industry Value Chain
10.2 Antidiabetics Upstream Market
10.3 Antidiabetics Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Antidiabetics Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Antidiabetics in Global Market
Table 2. Top Antidiabetics Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Antidiabetics Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Antidiabetics Revenue Share by Companies, 2018-2023
Table 5. Global Antidiabetics Sales by Companies, (K Units), 2018-2023
Table 6. Global Antidiabetics Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Antidiabetics Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Antidiabetics Product Type
Table 9. List of Global Tier 1 Antidiabetics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Antidiabetics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Antidiabetics Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Antidiabetics Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Antidiabetics Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Antidiabetics Sales (K Units), 2018-2023
Table 15. By Type - Global Antidiabetics Sales (K Units), 2024-2029
Table 16. By Application – Global Antidiabetics Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Antidiabetics Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Antidiabetics Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Antidiabetics Sales (K Units), 2018-2023
Table 20. By Application - Global Antidiabetics Sales (K Units), 2024-2029
Table 21. By Region – Global Antidiabetics Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Antidiabetics Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Antidiabetics Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Antidiabetics Sales (K Units), 2018-2023
Table 25. By Region - Global Antidiabetics Sales (K Units), 2024-2029
Table 26. By Country - North America Antidiabetics Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Antidiabetics Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Antidiabetics Sales, (K Units), 2018-2023
Table 29. By Country - North America Antidiabetics Sales, (K Units), 2024-2029
Table 30. By Country - Europe Antidiabetics Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Antidiabetics Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Antidiabetics Sales, (K Units), 2018-2023
Table 33. By Country - Europe Antidiabetics Sales, (K Units), 2024-2029
Table 34. By Region - Asia Antidiabetics Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Antidiabetics Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Antidiabetics Sales, (K Units), 2018-2023
Table 37. By Region - Asia Antidiabetics Sales, (K Units), 2024-2029
Table 38. By Country - South America Antidiabetics Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Antidiabetics Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Antidiabetics Sales, (K Units), 2018-2023
Table 41. By Country - South America Antidiabetics Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Antidiabetics Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Antidiabetics Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Antidiabetics Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Antidiabetics Sales, (K Units), 2024-2029
Table 46. Sanofi-Aventis Company Summary
Table 47. Sanofi-Aventis Antidiabetics Product Offerings
Table 48. Sanofi-Aventis Antidiabetics Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. Sanofi-Aventis Key News & Latest Developments
Table 50. Takeda Pharmaceuticals Company Summary
Table 51. Takeda Pharmaceuticals Antidiabetics Product Offerings
Table 52. Takeda Pharmaceuticals Antidiabetics Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. Takeda Pharmaceuticals Key News & Latest Developments
Table 54. Eli Lilly Company Summary
Table 55. Eli Lilly Antidiabetics Product Offerings
Table 56. Eli Lilly Antidiabetics Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. Eli Lilly Key News & Latest Developments
Table 58. Oramed Pharmaceuticals Company Summary
Table 59. Oramed Pharmaceuticals Antidiabetics Product Offerings
Table 60. Oramed Pharmaceuticals Antidiabetics Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. Oramed Pharmaceuticals Key News & Latest Developments
Table 62. Boehringer Ingelheim Company Summary
Table 63. Boehringer Ingelheim Antidiabetics Product Offerings
Table 64. Boehringer Ingelheim Antidiabetics Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 65. Boehringer Ingelheim Key News & Latest Developments
Table 66. Merck & Co. Inc. Company Summary
Table 67. Merck & Co. Inc. Antidiabetics Product Offerings
Table 68. Merck & Co. Inc. Antidiabetics Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 69. Merck & Co. Inc. Key News & Latest Developments
Table 70. Novo Nordisk Company Summary
Table 71. Novo Nordisk Antidiabetics Product Offerings
Table 72. Novo Nordisk Antidiabetics Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 73. Novo Nordisk Key News & Latest Developments
Table 74. Bristol-Myers Squibb Company Summary
Table 75. Bristol-Myers Squibb Antidiabetics Product Offerings
Table 76. Bristol-Myers Squibb Antidiabetics Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 77. Bristol-Myers Squibb Key News & Latest Developments
Table 78. Halozyme Therapeutics Company Summary
Table 79. Halozyme Therapeutics Antidiabetics Product Offerings
Table 80. Halozyme Therapeutics Antidiabetics Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 81. Halozyme Therapeutics Key News & Latest Developments
Table 82. Pfizer Company Summary
Table 83. Pfizer Antidiabetics Product Offerings
Table 84. Pfizer Antidiabetics Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 85. Pfizer Key News & Latest Developments
Table 86. Antidiabetics Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 87. Global Antidiabetics Capacity Market Share of Key Manufacturers, 2021-2023
Table 88. Global Antidiabetics Production by Region, 2018-2023 (K Units)
Table 89. Global Antidiabetics Production by Region, 2024-2029 (K Units)
Table 90. Antidiabetics Market Opportunities & Trends in Global Market
Table 91. Antidiabetics Market Drivers in Global Market
Table 92. Antidiabetics Market Restraints in Global Market
Table 93. Antidiabetics Raw Materials
Table 94. Antidiabetics Raw Materials Suppliers in Global Market
Table 95. Typical Antidiabetics Downstream
Table 96. Antidiabetics Downstream Clients in Global Market
Table 97. Antidiabetics Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Antidiabetics Segment by Type in 2022
Figure 2. Antidiabetics Segment by Application in 2022
Figure 3. Global Antidiabetics Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Antidiabetics Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Antidiabetics Revenue, 2018-2029 (US$, Mn)
Figure 7. Antidiabetics Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Antidiabetics Revenue in 2022
Figure 9. By Type - Global Antidiabetics Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Antidiabetics Revenue Market Share, 2018-2029
Figure 11. By Type - Global Antidiabetics Sales Market Share, 2018-2029
Figure 12. By Type - Global Antidiabetics Price (USD/Unit), 2018-2029
Figure 13. By Application - Global Antidiabetics Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Antidiabetics Revenue Market Share, 2018-2029
Figure 15. By Application - Global Antidiabetics Sales Market Share, 2018-2029
Figure 16. By Application - Global Antidiabetics Price (USD/Unit), 2018-2029
Figure 17. By Region - Global Antidiabetics Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Antidiabetics Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Antidiabetics Revenue Market Share, 2018-2029
Figure 20. By Region - Global Antidiabetics Sales Market Share, 2018-2029
Figure 21. By Country - North America Antidiabetics Revenue Market Share, 2018-2029
Figure 22. By Country - North America Antidiabetics Sales Market Share, 2018-2029
Figure 23. US Antidiabetics Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Antidiabetics Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Antidiabetics Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Antidiabetics Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Antidiabetics Sales Market Share, 2018-2029
Figure 28. Germany Antidiabetics Revenue, (US$, Mn), 2018-2029
Figure 29. France Antidiabetics Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Antidiabetics Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Antidiabetics Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Antidiabetics Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Antidiabetics Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Antidiabetics Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Antidiabetics Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Antidiabetics Sales Market Share, 2018-2029
Figure 37. China Antidiabetics Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Antidiabetics Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Antidiabetics Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Antidiabetics Revenue, (US$, Mn), 2018-2029
Figure 41. India Antidiabetics Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Antidiabetics Revenue Market Share, 2018-2029
Figure 43. By Country - South America Antidiabetics Sales Market Share, 2018-2029
Figure 44. Brazil Antidiabetics Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Antidiabetics Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Antidiabetics Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Antidiabetics Sales Market Share, 2018-2029
Figure 48. Turkey Antidiabetics Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Antidiabetics Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Antidiabetics Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Antidiabetics Revenue, (US$, Mn), 2018-2029
Figure 52. Global Antidiabetics Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Antidiabetics by Region, 2022 VS 2029
Figure 54. Antidiabetics Industry Value Chain
Figure 55. Marketing Channels

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 抗糖尿病薬の世界市場見通し2023年-2029年(Antidiabetics Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

抗糖尿病薬の世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp